glp 1 receptor agonists incretin mimetics Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact Recent updates on GLP-1 agonists:

That's the big question

Kuss-Duerkop SK, Wang J, Mena I, White K, Metreveli G, Sakthivel R, et al

Timothy Garvey, M.D., co-author of a study published in JAMA (February 2022) and Butterworth Professor of Medicine in the Department of Nutrition Sciences, shared his insights: We have not seen this degree of weight loss with any previous medication. Not only is Semaglutide known for its success in treating type 2 diabetes, but it is proving to be just as effective for weight lossa double benefit in reducing weight and regulating blood sugar levels

As we age, B12 levels tend to decline, and low B12 levels and high homocysteine levels have been linked with dementia onset as well as several inflammatory diseases, but B12 injections restore B12 to healthy levels and reduce homocysteine (making it also beneficial for cardiovascular disease)-- see the infusions page for more info

Nonetheless, several positive trends in endpoints were observed in the treated group, [103] leading to wonder how to improve targeting of this agent to the most suitable SLE patients